Your browser doesn't support javascript.
loading
Expert opinion about laser and intense pulsed light (IPL)-induced leukoderma or vitiligo: a cross-sectional survey study.
Post, Nicoline F; Van Broekhoven, Noah X; Lommerts, Annelies; Bae, Jung M; Bekkenk, Marcel W; de Castro, Caio C Silva; Eleftheriadou, Viktioria; Esmat, Samia; Ezzedine, Khaled; van Geel, Nanja; Hamzavi, Iltefat; Leone, Giovanni; Pandya, Amit G; Passeron, Thierry; Rodrigues, Michelle A; Seneschal, Julien; Th'ng, Steven; Wolkerstorfer, Albert.
Afiliación
  • Post NF; Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. n.f.post@amsterdamumc.nl.
  • Van Broekhoven NX; Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Lommerts A; Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • Bae JM; Department of Dermatology, St. Vincent's Hospital, Seoul, South Korea.
  • Bekkenk MW; Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
  • de Castro CCS; Department of Dermatology, Pontifical Catholic University of Paraná, Curitiba, Brazil.
  • Eleftheriadou V; Department of Dermatology, The Royal Wolverhampton NHS Trust, Wolverhampton, UK.
  • Esmat S; Department of Dermatology, Cairo University, Giza, Egypt.
  • Ezzedine K; Department of Dermatology, Université Paris-Est Créteil Val de Marne-Université Paris, Paris, France.
  • van Geel N; Department of Dermatology, Ghent University Hospital, Ghent, Belgium.
  • Hamzavi I; Department of Dermatology, Henry Ford Health System, Detroit, MI, USA.
  • Leone G; Dermatology Department, Israelite Hospital, Rome, Italy.
  • Pandya AG; Department of Dermatology, Palo Alto Foundation Medical Group, Sunnyvale, CA, USA.
  • Passeron T; Department of Dermatology and INSERM U1065, University Hospital of Nice, Nice, France.
  • Rodrigues MA; Chroma Dermatology, Pigment and Skin of Colour Centre, Victoria, Australia.
  • Seneschal J; Department of Dermatology and Pediatric Dermatology, University Hospital, Bordeaux, France.
  • Th'ng S; Department of Dermatology, Skin Research Institute of Singapore, Singapore, Singapore.
  • Wolkerstorfer A; Department of Dermatology, Amsterdam University Medical Centers, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
Arch Dermatol Res ; 315(8): 2289-2294, 2023 Oct.
Article en En | MEDLINE | ID: mdl-36964767
ABSTRACT
Vitiligo patients may desire laser hair removal, skin rejuvenation, vascular treatments, and other laser or intense pulsed light (IPL) assisted treatments. However, there is a risk of inducing new depigmented patches (Koebner phenomenon). In absence of guidelines on the safe use of laser or IPL in vitiligo patients, dermatologists tend to be reluctant to administer these treatments. The aim of this survey study was to provide an estimation of the occurrence and related risk factors of laser/IPL-induced leukoderma or vitiligo. A cross-sectional survey study was performed among 15 vitiligo experts from 11 countries, with 14 questions about affected patients, involved laser/IPL treatments and the physicians' approach. In a total of 11,300 vitiligo patients, laser/IPL-induced leukoderma or vitiligo was reported in 30 patients (0.27%). Of these, 12 (40%) patients had a medical history of vitiligo and seven (58%) of these patients had stable (> 12 months) vitiligo before the treatment. Most frequently reported were hair removal procedures and localization of the face and legs. Side effects like blistering, crusting, and erosions occurred in 56.7% of the cases. These vitiligo experts based their advice on the risk of the laser treatment on stability of the vitiligo (43%) and activity signs (50%), and 50% discuss the risks before starting a laser treatment. Relevant activity signs are the Koebner phenomenon (57.1%), confetti-like lesions (57.1%) and hypochromic borders (50%). Laser-induced leukoderma or vitiligo is an uncommon phenomenon. Remarkably, a minority had a medical history of vitiligo of which 58% were stable. Consequently, most cases could not have been prevented by not treating vitiligo patients. However, a majority had laser/IPL-induced skin damage. Therefore, caution is advised with aggressive settings and test-spots prior to the treatment are recommended. This study showed significant variation in the current recommendations and approach of vitiligo experts regarding laser/IPL-induced leukoderma or vitiligo.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Hipopigmentación / Tratamiento de Luz Pulsada Intensa Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Arch Dermatol Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vitíligo / Hipopigmentación / Tratamiento de Luz Pulsada Intensa Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Qualitative_research / Risk_factors_studies Límite: Humans Idioma: En Revista: Arch Dermatol Res Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos